Prof. Dr. med. Ricardo Grieshaber Bouyer

Professur für Klinische Systemimmunologie Department of Medicine 3 – Rheumatology and Immunology

Tiny warriors, big impact: targeted immunotherapy in kidney diseases (2026) Kurzhagen J, Laqua W, Schett G, Grieshaber Bouyer R, Rabb H, Noel S, Schiffer M Journal article, Review article Roads and detours for CAR T cell therapy in autoimmune diseases (2026) Avouac J, Barzel A, Caiati D, Davis RS, Gottschalk S, Grieshaber Bouyer R, Mao X, et al. Journal article, Review article Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases (2026) Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, et al. Journal article Soluble BDCA-2 as a potential biomarker for rheumatoid arthritis and its role in enhancing IFN-α production through nucleic acid binding (2026) Mainieri L, Kaufmann A, Bucci L, Grieshaber Bouyer R, Bauer S, Venegas-Solis F Journal article Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy (2025) Freitag M, Kolb P, Falcone V, Claus M, Schröder P, Andreeva I, Rodon L, et al. Journal article BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025) Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, et al. Journal article From complexity to consensus: A roadmap for neutrophil classification (2025) Ng LG, Ballesteros I, Cassatella MA, Egeblad M, Fridlender ZG, Gabrilovich D, Gao Q, et al. Journal article, Review article Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis (2025) Ostendorf L, Garantziotis P, Huang FY, Schett G, Lederer JA, Fava A, Rao DA, Grieshaber Bouyer R Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes (2025) Taubmann J, Böltz S, Hagen M, Wirsching A, Müller F, Völkl S, Kharboutli S, et al. Journal article